Ambry Becomes CSP for Roche NimbleGen Offerings | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Ambry Genetics has been named a certified service provider for several product offerings from Roche NimbleGen.

Aliso Viejo, Calif.-based Ambry will offer services using Nimblegen's comparative genomic hybridization, chromatin immunoprecipitation-on-chip, DNA methylation, and gene expression tools. The addition of these applications means that Ambry is now certified on all Roche NimbleGen applications, Roche said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harold Varmus, a former NIH director, says that proposed reductions to the agency's budget are worrisome.

The Genome 10K project is to sequence about 10,000 vertebrate genomes, including ones of endangered species, Digital Trends reports.

The new Coalition to Save NIH Funding aims to educate lawmakers and the public on the significance of biomedical research.

In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.